Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00911443
What this trial is testing

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
sigma-tau i.f.r. S.p.A. 488
Not applicableEnded earlyNCT04249115
What this trial is testing

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

Who this might be right for
Lesion SkinSeborrheic KeratosisSkin Lesion+1 more
Pulse Biosciences, Inc. 175
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Not applicableLooking for participantsNCT04654208
What this trial is testing

Swedish Ibrance Registries Insights (SIRI)

Who this might be right for
Malignant Neoplasm of Breast
Pfizer 1,500
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)UnknownNCT05133674
What this trial is testing

Therapeutic Dose Monitoring (TDM) of Tamoxifen

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+2 more
Karolinska University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT05180474
What this trial is testing

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Who this might be right for
Breast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more
Genmab 179
Testing effectiveness (Phase 2)Ended earlyNCT00003552
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV MelanomaRecurrent Melanoma
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT00060125
What this trial is testing

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Not applicableStudy completedNCT03607578
What this trial is testing

Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations

Who this might be right for
SunburnUltraviolet Radiation ExposureSkin Cancer+3 more
Brian Køster 1,548
Early research (Phase 1)Looking for participantsNCT07524855
What this trial is testing

JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Janssen Research & Development, LLC 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Ended earlyNCT02410863
What this trial is testing

Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 10
Early research (Phase 1)Study completedNCT03291938
What this trial is testing

IACS-010759 in Advanced Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Not applicableStudy completedNCT01288963
What this trial is testing

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Beth Israel Deaconess Medical Center 153
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Large-scale testing (Phase 3)Study completedNCT00003647
What this trial is testing

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Next Page